Middle East and Africa Intradermal Injections Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Method (Normal Sized Needles, Short Needle, and Without Needle), Application (Tuberculin Skin Test, Allergy Test, Local Aesthetics, and Others

Middle East and Africa Intradermal Injections Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Method (Normal Sized Needles, Short Needle, and Without Needle), Application (Tuberculin Skin Test, Allergy Test, Local Aesthetics, and Others), End User (Hospitals, Diagnostic Laboratories, Academics and Research Institutes, and Others)

The Middle East & Africa intradermal injections market is expected to reach US$ 302.3 million by 2028 from US$ 139.1 million in 2021; it is estimated to grow at a CAGR of 10.2% from 2021 to 2028. Manufacturers in the intradermal injection market are adopting various developmental strategies, such as partnerships, collaborations, product launches, approvals, and mergers and acquisitions, to sustain the competitive environment and strengthen their presence in the market, as well as to boost the clinical research work for speeding up the development of various new candidates. For instance, Inviragen and PharmaJet collaboration received an investment of US$ 15.5 million for investigational dengue vaccine i.e. DENVax via Pharmajet’s needle free injection device. Similarly, in November 2020, Pharmajet collaborated with Diomics to incorporate the needle-free technology for determining immune response to a SARS-CoV-2 protein. Along with this, Crossject and Cenexi entered in partnership in 2016 to develop needle-free auto injector named Zeneo. The medical equipment manufacturers across the region are scaling up the production of their devices. Their involvement in various business developments and product innovations helps ensure the easy availability of the products in the Middle East & Africa markets. Moreover, the regulatory agencies are providing the required support through timely product approvals and permissions. Such strategic activities by manufacturers are expected to propel the growth of the intradermal injection market in coming years.

Based on method, the intradermal injections market is segmented into normal-sized needles, short needles, and without needles. In 2020, the normal-sized needles segment accounted for the largest share, short needles segment is expected to grow at the highest CAGR in the forecast period.

The COVID-19 pandemic boosted the demand for medical devices used in a home care setting, as people’s visit to hospitals was restricted to control the spread of infection. The Middle East & Africa observed a rising number of patients admitted to intensive care units (ICU), which increased the number of medications imposing multiple diagnostic and therapeutic challenges on stressed healthcare systems, leading to a rise in medical devices. Several companies experienced changes related to staff allocations and work hours and the implementation of stringent infection control and social distancing measures. Moreover, they faced mental, physical, emotional, and financial challenges. The import of various drugs and medical devices was also impacted. However, medical industry segments, including intradermal injections, experienced reduction in growth during the COVID-19 pandemic due to restricted manufacturing and supply chain facilities. Also, the number of chronic conditions cases has increased, which resulted in an increased diagnosis of tuberculosis and skin allergies. The pandemic affected the business operation of the various key players operating in the intradermal injection market in the region.

The overall Middle East & Africa intradermal injections market size has been derived using both primary and secondary sources. To begin the research process, exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the market. The process also serves the purpose of obtaining an overview and forecast for the Middle East & Africa intradermal injections market with respect to all the segments pertaining to the region. Also, multiple primary interviews have been conducted with industry participants and commentators to validate the data, as well as to gain more analytical insights into the topic. Participants of this process include industry experts such as VPs, business development managers, market intelligence managers, and national sales managers, along with external consultants such as valuation experts, research analysts, and key opinion leaders, specializing in the Middle East & Africa intradermal injections market. Companies adopt a few strategies, such as mergers and acquisitions and market initiatives, which promotes market growth. BD, West Pharmaceutical Services, Inc., Terumo Corporation, NanoPass, Pharmajet, Idevax, EUNSUNG GLOBAL, Crossject, Cardinal Health Inc., and Hindustan Syringes and Medical Devices Ltd are among the major players operating in the market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa intradermal injections market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa intradermal injections market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.